CIK 0001376339 · Large accelerated filer
MIMEDX GROUP, INC.
Sign in to watch- Ticker
- MDXG
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 262792552
- Phone
- (770) 651-9100
- Business address
- 1775 W OAK COMMONS COURT, NE, MARIETTA, GA, 30062
- Former names
- Alynx, Co.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-15 | Whitlow Ricci S Chief Operating Officer | Sale | −15,198 | $8.06 | $122K | 431,814 |
| 2024-02-14 | Whitlow Ricci S Chief Operating Officer | Sale | −15,845 | $8.03 | $127K | 447,012 |
| 2023-12-22 | Falcon Fund 2 Holding Company, L.P. 10% owner | Conversion | +28,195,249 | 28,195,249 | ||
| 2023-12-22 | Falcon Fund 2 Holding Company, L.P. 10% owner | Conversion · Series B Preferred Stock, par value $0.001 per share | −90,000 | 0 | ||
| 2023-11-21 | DOUG RICE Chief Financial Officer | Purchase | +5,000 | $7.16 | $36K | 102,200 |
| 2023-07-05 | DOUG RICE Chief Financial Officer | Grant or award | +97,200 | 97,200 | ||
| 2023-07-05 | DOUG RICE Chief Financial Officer | Grant or award · Stock Options | +94,000 | 94,000 | ||
| 2023-06-23 | Capper Joseph H Chief Executive Officer | Purchase | +42,025 | $6.50 | $273K | 100,000 |
| 2023-06-22 | Capper Joseph H Chief Executive Officer | Purchase | +57,975 | $6.33 | $367K | 57,975 |
| 2023-06-13 | BIERMAN JAMES L Director | Grant or award | +35,354 | $4.95 | $175K | 160,972 |
| 2023-06-13 | BEHRENS M KATHLEEN Director | Grant or award | +35,354 | $4.95 | $175K | 160,972 |
| 2023-06-13 | GARDNER PHYLLIS Director | Grant or award | +35,354 | $4.95 | $175K | 117,024 |
| 2023-06-13 | Giuliani Michael J Director | Grant or award | +35,354 | $4.95 | $175K | 130,124 |
| 2023-06-13 | HAWKINS WILLIAM A Director | Grant or award | +35,354 | $4.95 | $175K | 152,219 |
| 2023-06-13 | Newton Todd Director | Grant or award | +35,354 | $4.95 | $175K | 360,972 |
| 2023-06-13 | LAURENCIN CATO T Director | Grant or award 10b5-1 | +35,354 | $4.95 | $175K | 130,124 |
| 2023-05-16 | Stein Robert Benjamin President, Regenerative Med. | Sale | −10,365 | $5.95 | $62K | 317,803 |
| 2023-05-15 | Stein Robert Benjamin President, Regenerative Med. | Sale | −3,607 | $6.15 | $22K | 328,168 |
| 2023-05-10 | Hulse William Frank IV General Counsel and CAO | Sale | −5,870 | $5.93 | $35K | 456,564 |
| 2023-05-10 | Stein Robert Benjamin President, Regenerative Med. | Sale | −5,869 | $5.93 | $35K | 331,775 |
Page 5 of 7 · 126 trades